IL-8 receptor-modified CD70 CAR T cells

· University of Florida

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-8 receptor-modified CD70 CAR T cells, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Pediatric High-grade Glioma (HGG) [Phase 1]